Duke Studying Impact Of Clinical Trial Coverage On Enrollment For CMS
Executive Summary
BALTIMORE - With anecdotal evidence suggesting that insurance coverage for treatment expenses associated with clinical trials may affect study participation, CMS has contracted with Duke University to conduct a more systematic evaluation of the issue
You may also be interested in...
Third-Party Payer Effect On Clinical Trials Still Difficult To Quantify
Third-party payer policies appear to have an effect on clinical trial participation, but the impact "is difficult" to quantify, according to a draft report by Duke Evidence-Based Practice Center researchers prepared for the Agency for Healthcare Research and Quality
Third-Party Payer Effect On Clinical Trials Still Difficult To Quantify
Third-party payer policies appear to have an effect on clinical trial participation, but the impact "is difficult" to quantify, according to a draft report by Duke Evidence-Based Practice Center researchers prepared for the Agency for Healthcare Research and Quality
Patient Registries’ Impact On Clinical Trials Debated At IoM, CMS Meetings
The growing use of patient registries is sparking debate on how they impact participation in randomized clinical trials, long considered the gold standard for any kind of medical data gathering